期刊文献+

神经内分泌瘤488例临床病理特征及预后分析 被引量:5

Clinicopathological features and prognosis of 488 patients with neuroendocrine tumors
原文传递
导出
摘要 目的探讨神经内分泌瘤(NETs)的临床病理特点,分析其治疗方法及预后。方法回顾性分析郑州大学第一附属医院2012年10月至2017年10月病理确诊为NETs的488例患者的临床病理资料,包括原发部位、发病年龄、性别、转移部位、初诊症状、病理特征、治疗方法及预后。结果共488例患者,男女之比为1∶1.1,年龄(51.0±15.8)岁,病灶位于消化系统370例,肺63例,纵隔14例,其他部位34例,原发灶不明7例,直肠、胃、胰腺是最常见的发病部位。消化系统NETs中G1期190例(51.4%),G2期143例(38.6%),NET-G3期37例(10.0%)。肺NETs中类癌30例(47.6%),不典型类癌33例(52.4%)。临床分期为Ⅰ/Ⅱ期310例(63.5%),Ⅲ期53例(10.9%),Ⅳ期69例(14.1%),无法判断56例(11.5%)。单因素分析显示,NETs患者年龄>50岁、分级、分期、未行手术、肿瘤原发部位、远处转移、淋巴结转移是影响预后的危险因素。多因素Cox回归分析显示,年龄>50岁(HR=2.831,95%CI:1.414~7.029,P=0.025)、远处转移(HR=10.208,95%CI:4.110~25.355,P<0.001)是患者死亡的独立危险因素。结论NETs以直肠、胰腺、胃最为多见,预后较好。年龄和远处转移为影响NETs预后的独立危险因素。 Objective To investigate the clinicopathological features and prognosis of patients with neuroendocrine tumors (NETs). Methods The clinicopathologic data of enrolled patients with NETs between October 2012 and October 2017 at the First Affiliated Hospital of Zhengzhou University were retrospectively analyzed. Results Among the 488 NETs patients, the average age was (51.0±15.8) years, and the sex ratio (male/female) was 1∶1.1. Of the NETs, 370 were located in the digestive system (75.8%), 63 were pulmonary (12.9%), 14 were mediastinal (2.9%), 7 were of unknown primary origin (1.4%), and 34 were located in other sites (7.0%). Among the NETs, the pancreas, rectum and stomach were the most common sites. In the digestive system NETs, the most common tumor grade was G1 (190 cases, 51.4%), followed by G2 (143 cases, 38.6%) and NET-G3 (37 cases, 10.0%). In pulmonary NETs, typical and atypical carcinoid tumors was 47.6% and 52.4%, respectively. There were 310 patients at stage Ⅰ/Ⅱ, 53 at stage Ⅲ, 69 at stage Ⅳ and 56 at stage undiagnosed, respectively. The relationships among age, stage, grade, metastasis, treatment and prognosis were analyzed. All these factors could influence the survival rate of NET patients. Multivariate Cox analysis showed that age (>50 years old)(HR=2.831, 95%CI:1.414-7.029, P=0.025) and distant metastasis (HR=10.208, 95%CI:4.110-25.355, P<0.001) were independent risk factors. Conclusions The most common primary sites of NETs are the pancreas, rectum, and stomach. Age and distant metastasis are independent risk factors for the prognosis of NETs.
作者 翟雪佳 于顺利 马怡晖 王丰 杨闽洁 连妤瑾 余旭旭 樊青霞 宋丽杰 Zhai Xuejia;Yu Shunli;Ma Yihui;Wang Feng;Yang Minjie;Lian Yujin;Yu Xuxu;Fan Qingxia;Song Lijie(Department of Oncology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China;Department of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China;Department of Pathology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China)
出处 《中华医学杂志》 CAS CSCD 北大核心 2019年第32期2527-2531,共5页 National Medical Journal of China
关键词 神经内分泌瘤 病理状态 体征和症状 治疗 预后 Neuroendocrine tumors Pathological conditions, signs and symptoms Treatment Prognosis
  • 相关文献

参考文献4

二级参考文献21

  • 1Yao JC,Hassan M,Phan A. One hundred years after "carcinoid":epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States[J].Journal of Clinical Oncology,2008,(18):3063-3072.doi:10.1200/JCO.2007.15.4377.
  • 2Orloff MJ. Carcinoid tumors of the rectum[J].Cancer,1971.175-180.
  • 3Naunheim KS,Zeitels J,Kaplan EL. Rectal carcinoid tumors-treatment and prognosis[J].Surgery,1983.670-676.
  • 4Bagheri R,Mashhadi Mt,Haghi SZ. Tracheobronchopulmonary carcinoid tumors:analysis of 40 patients[J].Annals of Thoracic and Cardiovascular Surgery,2011.7-12.
  • 5Oberg K. Carcinoid tumors:current concepts in diagnosis and treatment[J].Oncologist(The),1998.339-345.
  • 6Pape UF,Jann H,Müller-Nordhorn J. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors[J].Cancer,2008.256-265.
  • 7Sarmiento JM,Heywood G,Rubin J. Surgical treatment of neuroendocrine metastases to the liver:a plea for resection to increase survival[J].Journal of the American College of Surgeons,2003.29-37.
  • 8Akerstr~m G,Hellman P. Surgery on neuroendocrine tumours[J].Best Practice and Research:Clinical Endocrinology and Metabolism,2007.87-109.
  • 90berg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours[J].Annals of Oncology,2001,(Suppl 2):S111-S114.
  • 10Quaedvlieg PF,Visser O,Lamers CB. Epidemiology and survival in patients with carcinoid disease in The Netherlands.An epidemiological study with 2391 patients[J].Annals of Oncology,2001.1295-1300.

共引文献217

同被引文献30

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部